Copyright
©The Author(s) 2023.
World J Gastroenterol. Jul 7, 2023; 29(25): 4053-4071
Published online Jul 7, 2023. doi: 10.3748/wjg.v29.i25.4053
Published online Jul 7, 2023. doi: 10.3748/wjg.v29.i25.4053
Figure 8 The summary of dysregulated cell cycle and Notch pathways in cholangiocarcinoma progression.
The cholangiocarcinogenesis driven by aberrant cell cycle and Notch pathways, which may be targeted by small molecular inhibitors.
- Citation: Liu D, Shi Y, Chen H, Nisar MA, Jabara N, Langwinski N, Mattson S, Nagaoka K, Bai X, Lu S, Huang CK. Molecular profiling reveals potential targets in cholangiocarcinoma. World J Gastroenterol 2023; 29(25): 4053-4071
- URL: https://www.wjgnet.com/1007-9327/full/v29/i25/4053.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i25.4053